In vivo MRI signatures of hippocampal subfield pathology in patients with Parkinson’s disease and psychosis
Objective: To study the role of hippocampal subfield pathology in the genesis of psychotic symptoms in patients with Parkinson's disease (PD) by comparing the volumes…Derivation and characterization of Parkinson’s disease related pattern using functional magnetic resonance imaging
Objective: This study attempts to identify Parkinson’s disease-related pattern in Japan using functional magnetic resonance imaging (fMRI), and to characterize this pattern. Background: Parkinson’s disease-related…Objective and quantifiable assessment of sleep in patients with Parkinson’s disease using a wearable sensor
Objective: To explore the feasibility of using a body-fixed sensor (BFS) to assess sleep disturbances in patients with Parkinson's disease (PD), carriers and non-carriers of…Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson’s disease?
Objective: To determine if REM sleep behavior disorder (RBD) is associated with excessive daytime sleepiness (ES) in military veterans with Parkinson’s disease (PD). Background: Nearly…Commonalities of prodromal non-motor symptoms between movement disorders
Objective: This study reviewed and compared evidence of nonmotor symptoms in prodromal phases in movement disorders including Parkinson disease, Atypical Parkinsonism (MSA, DLB, PSP), Huntington…Comorbid REM sleep behavior disorder and impulse control disorder symptoms in early parkinson’s disease: The PPMI cohort
Objective: To assess the prevalence of Impulse Control Disorder symptoms (ICD) in Parkinson's disease with probable REM sleep behavior disorder (i.e. RBD assessed by questionnaire,…Cell and animal models lacking RAB39B show biochemical and behavioural phenotypes that model aspects of Parkinson’s disease
Objective: To determine the pathogenic mechanisms underlying RAB39B-mediated Parkinson’s disease (PD). Background: PD is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the…Microbiota DNA in the blood of patients with Parkinson’s disease
Objective: The aim of this study was to explore the blood microbiota compositions in Chinese patients with Parkinson’s disease (PD). Background: Emerging evidences suggest that…α-synuclein antibody 5G4 identifies manifest and prodromal Parkinson’s disease in colonic mucosa
Objective: The aim of this study was to evaluate colonic mucosa staining using the 5G4 antibody, specific only for the disease-associated form of α-synuclein, in…Naturalistic-based UPDRS-III Minimal Clinically Important Difference (MCID) in early PD
Objective: To find the MCID of the UPDRS-III subscale in early PD subjects, when started on a new dopaminergic drug. Background: The concept of Minimally…
- « Previous Page
- 1
- …
- 250
- 251
- 252
- 253
- 254
- …
- 405
- Next Page »
